Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Curcumin vs Tetrahydrocurcumin: their evidence isn't directly comparable (one is unscored); they're alternatives for brain aging support — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Curcumin wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
3 of 5 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Curcumin and Tetrahydrocurcumin have evidence — compare verdict strength side-by-side.
500-1000mg daily (enhanced form)
With fatty meal
Enhanced absorption form: Longvida, Meriva, or BCM-95
No established human dose. The one oral human pilot used 200 mg/day; supplement products typically supply 250–500 mg/day. Dosing is not evidence-based.
With a fat-containing meal (by analogy to curcumin)
Oral tetrahydrocurcumin capsule
4-8 weeks
4-8 weeks
4-8 weeks
Immediate
Unknown in humans
Unknown in humans
~4 weeks (single pilot)
N/A
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials
Phytotherapy research : PTR (2024) · Meta analysis · n=7216
We meta-analyzed the effect sizes across eligible studies using the random-effects model.
Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis
Psychological medicine (2025) · Meta analysis · n=17437
Network meta-analysis of 192 trials in 17,437 adults with depressive disorder, covering 44 nutraceuticals.
The role of tetrahydrocurcumin in disease prevention and treatment
Food & Function (2024) · Review
Review of THC's research progress in neurological disorders, metabolic syndromes, cancers, and inflammatory diseases.
Tetrahydrocurcumin for Major Depressive Disorder with Therapeutic Potential and Mechanistic Insights from Clinical and Preclinical Studies
Molecular Neurobiology (2025) · Pilot · n=19
A randomized, open-label pilot in 19 patients with major depressive disorder: escitalopram 10 mg/day alone or with 200 mg/day THC for 29 days, with blinded raters. Sixteen completed the primary assessment.
Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses
Molecules (2014) · Review
Mechanistic review directly comparing curcumin and its metabolite THC.
Curcumin has gradable evidence while Tetrahydrocurcumin has insufficient evidence to score and wins in 1 of 3 categories.
For brain aging support, Curcumin has a higher relevance score (40 vs 35).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
Curcumin, omega-3, UC-II collagen, Boswellia vs the old glucosamine default — and OA vs RA.
When to take what, with or without food, and which supplements compete vs pair well.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.